Results for tag: "Mavenclad"

Mavenclad is a drug used to treat multiple sclerosis (MS), a chronic, progressive neurological disorder. It is a disease-modifying therapy (DMT) that works by reducing the frequency and severity of MS relapses. Mavenclad is a type of central nervous system (CNS) drug, which are drugs that act on the brain and spinal cord to treat neurological disorders. CNS drugs are used to treat a wide range of conditions, including Alzheimer's disease, Parkinson's disease, epilepsy, and depression. Mavenclad is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2019. It is the first oral DMT to be approved for the treatment of MS, and is considered to be a breakthrough in the treatment of the disease. Companies in the Mavenclad market include Merck KGaA, EMD Serono, and Biogen. Show Less Read more